We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

19 May 2026 - 22 May 2026
17 Jun 2026 - 19 Jun 2026
05 Oct 2026 - 06 Oct 2026

Single-Handed Suturing Device Advances Vascular Surgery

By HospiMedica International staff writers
Posted on 19 Oct 2016
A disposable precision instrument enables surgeons to suture tubular and layered structures using just one hand, and at twice the speed of conventional suturing.

The Switch Platform is based on a straight needle positioned in a needle holder, which is placed inside a forceps-like device. More...
The needle is passed through the tissue, and is then recovered by a second needle holder on the other jaw of the forceps. The needle is then repositioned inside the needle holder and the process is repeated to the reverse direction; the procedure is thus repeated with every suture. This repetitive sequence allows for continuous suturing in a predictable linear path, resulting in less motion friction and damage to the vessel wall.

The Switch can be operated by lightly pinching the double-action buttons on the side with the thumb and index finger of one hand; the other hand is free to present the tissue to be sutured. The technique greatly improves the precision and efficiency of the suturing process, as surgeons no longer need to switch the needle between instruments, and can focus on getting control over the tissue instead. It also reduces operational time, as on average 30% of the operation time is spent on suturing.

Future developments include Switch devices with varying geometries; a micro surgery model for coronary artery and arteriovenous fistula procedures; laparoscopic and robotic variants; a reusable electrical model with exchangeable jaws; a 10 cm version; and diversification in suture material, including polydioxanone (PDS) and vicryl. The Switch is a product of Mellon Medical (Nijmegen, The Netherlands), and will initially focus on three vascular indications: carotid artery surgery, kidney transplant, and peripheral bypass surgery.

“By collaborating with medical specialists, industrial designers, and ergonomic experts in the development of the Switch, Mellon has been able to reinvent suturing, bringing suturing technology into the 21st century,” said vascular surgeon Mark Vrancken Peeters, MD, chief medical officer of Mellon Medical. “Our mission is to improve medical procedures by providing the best possible tools. We believe our innovative platform suturing technology will improve patient outcome and reduce overall healthcare costs.”

Related Links:
Mellon Medical


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Desk Aneroid Sphyg
Diagnostix 750D+
New
Medical Examination & Procedure Light
Vega 80
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A high‑frequency ultrasound can inactivate enveloped respiratory viruses while sparing human cells (image credit: Adobe Stock)

High-Frequency Ultrasound Disables Viruses While Sparing Human Cells

Respiratory viral infections such as influenza A and COVID-19 continue to challenge patient management. Antiviral drugs are generally difficult to develop, and safe, broadly applicable options remain limited.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.